Immunomodulation of Memory-Impairing Protein Tau in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1660-2862|10|1-4|242-245

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.10, Iss.1-4, 2012-03, pp. : 242-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transition of Tau Protein from Disordered to Misordered in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-02 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Alzheimer’s as a metabolic disease

By Demetrius Lloyd   Driver Jane  

Biogerontology, Vol. 14, Iss. 6, 2013-12 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Retromers in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-03 ,pp. : 116-121

Karger

Access to resources Recommend Favorite

Tau as the Converging Protein between Chronic Stress and Alzheimer's Disease Synaptic Pathology

By  

Neurodegenerative Diseases, Vol. 16, Iss. 1-2, 2016-0 ,pp. : 22-25

Karger

Access to resources Recommend Favorite

TAU Haplotype and the Saitohin Q7R Gene Polymorphism Do Not Influence CSF Tau in Alzheimer’s Disease and Are Not Associated with Frontotemporal Dementia or Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 1, 2005-08 ,pp. : 28-35

Karger

Access to resources Recommend Favorite